Regenerative medicine for the central nervous system - Transplantation of neural stem cells into the injured spinal cord -

Shinjiro Kaneko, Masaya Nakamura, Yuto Ogawa, Koota Watanabe, Akio Iwanami, Yoshiaki Toyama, Hideyuki Okano

Research output: Contribution to journalArticle

Abstract

Advances in the stem cell biology of the central nervous system (CNS) and other studies enhance the possibility of regeneration of the damaged CNS, which has previously been considered to be almost impossible. The availability of signals to induce the appropriate differentiation of the transplanted and/or endogenous neural stem cells (NSCs) as well as the timing of the transplantation are vital factors for improving the functional recovery of the damaged CNS. Because the immediate post-traumatic microenvironment of the spinal cord is in an acute inflammatory stage, it does not favor the survival and differentiation of the transplants. Furthermore, in the chronic disease stage after injury, glial scars that inhibit the regeneration of neuronal axons form in the injured site. Thus, we consider that the optimal period of transplantation is 1-2 weeks after injury.

Original languageEnglish
Pages (from-to)68-80
Number of pages13
JournalJapan Medical Association Journal
Volume48
Issue number2
Publication statusPublished - 2005 Feb

Fingerprint

Regenerative Medicine
Neural Stem Cells
Spinal Cord
Central Nervous System
Transplantation
Regeneration
Wounds and Injuries
Neuroglia
Cicatrix
Axons
Cell Biology
Chronic Disease
Stem Cells
Transplants

Keywords

  • Axonal growth inhibitors
  • Central nervous system
  • Neural stem cells
  • Regeneration
  • Spinal cord injury
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Regenerative medicine for the central nervous system - Transplantation of neural stem cells into the injured spinal cord -. / Kaneko, Shinjiro; Nakamura, Masaya; Ogawa, Yuto; Watanabe, Koota; Iwanami, Akio; Toyama, Yoshiaki; Okano, Hideyuki.

In: Japan Medical Association Journal, Vol. 48, No. 2, 02.2005, p. 68-80.

Research output: Contribution to journalArticle

@article{0d6607cf2e244e7cbd81b7973a792ff3,
title = "Regenerative medicine for the central nervous system - Transplantation of neural stem cells into the injured spinal cord -",
abstract = "Advances in the stem cell biology of the central nervous system (CNS) and other studies enhance the possibility of regeneration of the damaged CNS, which has previously been considered to be almost impossible. The availability of signals to induce the appropriate differentiation of the transplanted and/or endogenous neural stem cells (NSCs) as well as the timing of the transplantation are vital factors for improving the functional recovery of the damaged CNS. Because the immediate post-traumatic microenvironment of the spinal cord is in an acute inflammatory stage, it does not favor the survival and differentiation of the transplants. Furthermore, in the chronic disease stage after injury, glial scars that inhibit the regeneration of neuronal axons form in the injured site. Thus, we consider that the optimal period of transplantation is 1-2 weeks after injury.",
keywords = "Axonal growth inhibitors, Central nervous system, Neural stem cells, Regeneration, Spinal cord injury, Transplantation",
author = "Shinjiro Kaneko and Masaya Nakamura and Yuto Ogawa and Koota Watanabe and Akio Iwanami and Yoshiaki Toyama and Hideyuki Okano",
year = "2005",
month = "2",
language = "English",
volume = "48",
pages = "68--80",
journal = "Asian Medical Journal",
issn = "1346-8650",
publisher = "Japan Medical Association",
number = "2",

}

TY - JOUR

T1 - Regenerative medicine for the central nervous system - Transplantation of neural stem cells into the injured spinal cord -

AU - Kaneko, Shinjiro

AU - Nakamura, Masaya

AU - Ogawa, Yuto

AU - Watanabe, Koota

AU - Iwanami, Akio

AU - Toyama, Yoshiaki

AU - Okano, Hideyuki

PY - 2005/2

Y1 - 2005/2

N2 - Advances in the stem cell biology of the central nervous system (CNS) and other studies enhance the possibility of regeneration of the damaged CNS, which has previously been considered to be almost impossible. The availability of signals to induce the appropriate differentiation of the transplanted and/or endogenous neural stem cells (NSCs) as well as the timing of the transplantation are vital factors for improving the functional recovery of the damaged CNS. Because the immediate post-traumatic microenvironment of the spinal cord is in an acute inflammatory stage, it does not favor the survival and differentiation of the transplants. Furthermore, in the chronic disease stage after injury, glial scars that inhibit the regeneration of neuronal axons form in the injured site. Thus, we consider that the optimal period of transplantation is 1-2 weeks after injury.

AB - Advances in the stem cell biology of the central nervous system (CNS) and other studies enhance the possibility of regeneration of the damaged CNS, which has previously been considered to be almost impossible. The availability of signals to induce the appropriate differentiation of the transplanted and/or endogenous neural stem cells (NSCs) as well as the timing of the transplantation are vital factors for improving the functional recovery of the damaged CNS. Because the immediate post-traumatic microenvironment of the spinal cord is in an acute inflammatory stage, it does not favor the survival and differentiation of the transplants. Furthermore, in the chronic disease stage after injury, glial scars that inhibit the regeneration of neuronal axons form in the injured site. Thus, we consider that the optimal period of transplantation is 1-2 weeks after injury.

KW - Axonal growth inhibitors

KW - Central nervous system

KW - Neural stem cells

KW - Regeneration

KW - Spinal cord injury

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=18044366166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18044366166&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 68

EP - 80

JO - Asian Medical Journal

JF - Asian Medical Journal

SN - 1346-8650

IS - 2

ER -